Advertisement
Advertisement

NVNO

NVNO logo

enVVeno Medical Corporation Common Stock

11.32
USD
Sponsored
+0.27
+2.46%
Apr 10, 12:54 UTC -4
Open

NVNO Earnings Reports

Positive Surprise Ratio

NVNO beat 13 of 23 last estimates.

57%

Next Report

Date of Next Report
Apr 28, 2026
Estimate for Q1 26 (Revenue/ EPS)
$510.00K
/
-$0.24
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
--
/
-96.88%

enVVeno Medical Corporation Common Stock earnings per share and revenue

On Feb 27, 2026, NVNO reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.28 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.85% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 510.00 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
logo
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
logo
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
logo
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
logo
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
logo
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
logo
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
logo
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
FAQ
For Q4 2025, enVVeno Medical Corporation Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved down -3.85%, changed from $10.40 before the earnings release to $10.00 the day after.
The next earning report is scheduled for Apr 28, 2026.
Based on 3 analysts, enVVeno Medical Corporation Common Stock is expected to report EPS of -$0.24 and revenue of $510.00K for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement